Showing results (171-180 of 185) with videos related to
Sort By:
Pageof 19
Bioconjugate Chemistry|November 19, 2010
One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)Carmen Wängler, Beatrice Waser, Andrea Alke, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosisRachida Lebtahi, Severine Moreau, Sylvain Marchand-Adam, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomasDamian Wild, Emanuel Christ, Martyn E Caplin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotideMarion De Jong, Roelf Valkema, Arthur Van Gameren, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2006
[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tateTheodosia Maina, Berthold A Nock, Paul Cordopatis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organsLeo J Hofland, Steven W J Lamberts, P Martin van Hagen, et al.Investigative Ophthalmology & Visual Science|July 5, 2008
Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptorStela S Palii, Aqeela Afzal, Lynn C Shaw, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance pStefan Kneifel, Dominik Cordier, Stephan Good, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging studyEmanuel Christ, Damian Wild, Susanne Ederer, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2011
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptidesPeter Laverman, Lieke Joosten, Annemarie Eek, et al.Pageof 19